JP2005511659A5 - - Google Patents

Download PDF

Info

Publication number
JP2005511659A5
JP2005511659A5 JP2003548863A JP2003548863A JP2005511659A5 JP 2005511659 A5 JP2005511659 A5 JP 2005511659A5 JP 2003548863 A JP2003548863 A JP 2003548863A JP 2003548863 A JP2003548863 A JP 2003548863A JP 2005511659 A5 JP2005511659 A5 JP 2005511659A5
Authority
JP
Japan
Prior art keywords
composition
kit
synergistic
lignan
cancer cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003548863A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005511659A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IN2001/000214 external-priority patent/WO2003047608A1/en
Publication of JP2005511659A publication Critical patent/JP2005511659A/ja
Publication of JP2005511659A5 publication Critical patent/JP2005511659A5/ja
Pending legal-status Critical Current

Links

JP2003548863A 2001-12-05 2001-12-05 癌の処置のための新規な草本化学組成物 Pending JP2005511659A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IN2001/000214 WO2003047608A1 (en) 2001-12-05 2001-12-05 A novel herbal chemical composition for the treatment of cancer

Publications (2)

Publication Number Publication Date
JP2005511659A JP2005511659A (ja) 2005-04-28
JP2005511659A5 true JP2005511659A5 (https=) 2005-12-22

Family

ID=11076415

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003548863A Pending JP2005511659A (ja) 2001-12-05 2001-12-05 癌の処置のための新規な草本化学組成物

Country Status (7)

Country Link
EP (1) EP1465645A1 (https=)
JP (1) JP2005511659A (https=)
KR (1) KR20040072646A (https=)
CN (1) CN100444837C (https=)
AU (1) AU2002222501A1 (https=)
CA (1) CA2469093A1 (https=)
WO (1) WO2003047608A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20106293A0 (fi) 2010-12-06 2010-12-06 Emilia Peuhu Uudet farmaseuttiset koostumukset
KR101416505B1 (ko) * 2012-03-15 2014-07-09 연세대학교 산학협력단 마타이레시놀을 포함하는 혈관신생 억제용 약제학적 조성물
CN104523721A (zh) * 2014-11-11 2015-04-22 济南星懿医药技术有限公司 一种抗肿瘤的药物组合物
CN109206394B (zh) * 2018-08-16 2022-04-01 广西壮族自治区中国科学院广西植物研究所 一种倍半木脂素化合物、其制备方法及应用
CN113633704B (zh) * 2021-08-23 2022-06-07 中山大学 一种细轴荛花叶提取物的制备方法及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6261565B1 (en) * 1996-03-13 2001-07-17 Archer Daniels Midland Company Method of preparing and using isoflavones

Similar Documents

Publication Publication Date Title
US6667337B2 (en) Combination therapy for cancer
US5798339A (en) Treatment method for cancer
ES2237110T3 (es) Uso de (+)-norcisaprida opticamente pura para tratar el sindrome del intestino irritable.
JP2008510758A5 (https=)
AU2009215329B2 (en) Combination comprising paclitaxel for treating ovarian cancer
JPH0635382B2 (ja) 抗不安薬としてのフルオキセチンの使用法
CN113925867A (zh) 盐酸决奈达隆联合5-氟尿嘧啶在制备抗肿瘤药物中的应用
WO2010071308A1 (ko) 암에 대한 방사선 치료 증진용 조성물
AR012731A1 (es) Uso de un derivado de taxano para la preparacion de una composicion farmaceutica , uso de un agente mejorador de la biodicponibilidad de dicho derivado forma de dosificacion oral y conjunto afrmaceutico que lo comprende y metodo para formar a un agente activo biodisponible.
JP2005511659A5 (https=)
DE60212710T2 (de) Pharmazeutische zubereitungen enthaltend epothilone und deren verwendung bei der behandlung von karzinoid
CA2028514C (en) Treatment of depression
CN111821303B (zh) 沃替西汀及其盐在制备抗肿瘤药物中的应用
CN112089710B (zh) 4-羟基异亮氨酸在制备抗肿瘤药物中的应用
IL43820A (en) Pharmacological preparations for the treatment of deformed disabled, containing symptomatic aminophytic bronchodilators
KR950703336A (ko) 악액질의 치료와 il-6 활성의 저해
CN105616411A (zh) 治疗结肠癌的组合物及其应用
US3497596A (en) Method of treating parkinsonism with morphanthridine derivatives
KR102578970B1 (ko) 2,3,5-치환된 싸이오펜 화합물의 난소암 예방, 개선 또는 치료 용도
CN102319260A (zh) 顺铂联合伊曲康唑异构体在制备治疗肺癌药物中的应用
CN115089576B (zh) 木犀草素和菊苣酸联合在制备乳腺癌治疗药物中的应用
JPH03502802A (ja) 抗嘔吐性エルゴリン誘導体
US8227515B2 (en) Use of hydroxamic acid derivatives for the preparation of anti-tumour medicaments
US20240156781A1 (en) Cancer therapeutic agent
JPWO2023177592A5 (https=)